Literature DB >> 23416017

Abnormal systolic and diastolic myocardial function in obese asymptomatic adolescents.

Arbnora Batalli-Këpuska1, Gani Bajraktari, Murat Zejnullahu, Mehmedali Azemi, Mujë Shala, Arlind Batalli, Pranvera Ibrahimi, Fisnik Jashari, Michael Y Henein.   

Abstract

Structural and functional cardiac changes are known in obese adults. We aimed to assess the relationship between body mass index (BMI) and cardiac function in overweight and obese asymptomatic adolescents. Ninety three healthy adolescents, aged 12.6 ± 1.2 years, received weight, height, BMI, waist, hips, waist/hips ratio assessment, hematology and biochemistry tests and an echocardiogram. Based on BMI, subjects were divided into: lean (L, n=32), overweight (Ov, n=33) and obese (Ob, n=32). Interventricular septal and LV posterior wall thickness were increased parallel to the BMI (L: 0.84 ± 0.1cm, Ov: 0.88 ± 0.1cm, Ob: 0.96 ± 0.1cm, p<0.001, and L: 0.78 ± 0.1cm, Ov: 0.8 ± 0.1cm, Ob: 0.94 ± 0.1cm, p<0.001, respectively) as were relative wall thickness (RWT) and mass index (LVMI) (L: 0.34 ± 0.05, Ov: 0.34 ± 0.05, Ob: 0.40 ± 0.04, p<0.001, and L: 47.7 ± 8.4 g/m(2), Ov: 51.9 ± 8.3g/m(2), Ob: 65.2 ± 13.3g/m(2), p=0<001, respectively). LV early diastolic (E') lateral and septal velocities (L: 15.3 ± 3.9 cm/s, Ov: 13.6 ± 4 cm/s, Ob: 10.5 ± 3.4 cm/s, p<0.001, and L: 12.2 ± 2.3 cm/s, Ov: 11.1 ± 2.4 cm/s, Ob: 9.8 ± 3.1cm/s, p=0.003, respectively), and systolic (S') velocities (L: 9.2 ± 1.4 cm/s, Ov: 9.3 ± 2.3 cm/s, Ob: 8.04 ± 1.5 cm/s, p=0.018, and L: 9.05 ± 2.3 cm/s, Ov: 9 ± 2.4 cm/s, Ob: 7.6 ± 1.1cm/s, p=0.014, respectively) were all reduced, only in obese adolescents. LV lateral E' (r=-0.44, p<0.001) and S' (r=-0.29, p=0.005) correlated with BMI. In asymptomatic adolescents, LV wall is thicker and diastolic function impaired and correlate with BMI. These findings demonstrate early cardiac functional disturbances which might explain the known obesity risk for cardiac disease.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adolescents; Body mass index; Echocardiography; Left ventricular function; Left ventricular mass index; Obesity

Mesh:

Year:  2013        PMID: 23416017     DOI: 10.1016/j.ijcard.2013.01.025

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

1.  Fibroblast growth factor-23 in obese, normotensive adolescents is associated with adverse cardiac structure.

Authors:  Farah N Ali; Bonita Falkner; Samuel S Gidding; Heather E Price; Scott W Keith; Craig B Langman
Journal:  J Pediatr       Date:  2014-07-22       Impact factor: 4.406

2.  No Obesity Paradox in Pediatric Patients With Dilated Cardiomyopathy.

Authors:  Chesney D Castleberry; John L Jefferies; Ling Shi; James D Wilkinson; Jeffrey A Towbin; Ryan W Harrison; Joseph W Rossano; Elfriede Pahl; Teresa M Lee; Linda J Addonizio; Melanie D Everitt; Justin Godown; Joseph Mahgerefteh; Paolo Rusconi; Charles E Canter; Steven D Colan; Paul F Kantor; Hiedy Razoky; Steven E Lipshultz; Tracie L Miller
Journal:  JACC Heart Fail       Date:  2018-02-07       Impact factor: 12.035

3.  Early ventricular remodeling and dysfunction in obese children and adolescents.

Authors:  Aura A Sanchez; Gautam K Singh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-10

4.  Effect of obesity on left ventricular longitudinal myocardial strain by speckle tracking echocardiography in children and adolescents.

Authors:  Ayşe Esin Kibar; Feyza Ayşenur Pac; İbrahim Ece; Mehmet Burhan Oflaz; Şevket Ballı; Veysel Nejat Bas; Zehra Aycan
Journal:  Balkan Med J       Date:  2015-01-01       Impact factor: 2.021

5.  Obesity and type 2 diabetes have additive effects on left ventricular remodelling in normotensive patients-a cross sectional study.

Authors:  Kirstie A De Jong; Juliane K Czeczor; Smithamol Sithara; Kevin McEwen; Gary D Lopaschuk; Alan Appelbe; Kimberly Cukier; Mark Kotowicz; Sean L McGee
Journal:  Cardiovasc Diabetol       Date:  2017-02-08       Impact factor: 9.951

Review 6.  The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin.

Authors:  Annayya R Aroor; Camila Manrique-Acevedo; Vincent G DeMarco
Journal:  Cardiovasc Diabetol       Date:  2018-04-18       Impact factor: 9.951

7.  Left Ventricular Diastolic and Systolic Functions in Patients with Hypothyroidism.

Authors:  Rina Tafarshiku; Michael Y Henein; Venera Berisha-Muharremi; Ibadete Bytyçi; Pranvera Ibrahimi; Afrim Poniku; Shpend Elezi; Gani Bajraktari
Journal:  Medicina (Kaunas)       Date:  2020-10-07       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.